Method for manufacturing a mold for a heart valve prosthesis
Patent Information
- Application Number
- JP2023559150
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-12-10
- Filing Date
- 2021-12-09
- Publication Date
- 2024-11-21
AI Technical Summary
Existing heart valve prostheses face issues with immune rejection and limited durability, particularly in bioprosthetic valves, necessitating frequent replacements and anticoagulant therapy, while autologous valves are scarce.
A method involving 3D imaging and reconstruction of a patient's defective heart valve to create a personalized mold for a heart valve prosthesis, optimized for improved functionality and durability, using techniques like injection molding or 3D printing.
The method produces a heart valve prosthesis with enhanced durability and reduced thrombus formation, avoiding immune rejection and the need for anticoagulation, while being cost-effective and adaptable to various types of heart valves.
Abstract
Description
Technical Field
[0001] The present invention relates to a method for manufacturing a mold for a heart valve prosthesis as described in the preamble of claim 1, a computer program product as described in the preamble of claim 7, and a mold for a heart valve prosthesis as described in the preamble of claim 9.
Background Art
[0002] In the prior art, it is known to replace heart valves with mechanical and biological heart valves.
[0003] The replacement of heart valves using mechanical heart valves has been established since the 1960s. Prostheses made of metal or plastic (polymers) are transplanted into patients by open heart surgery using cardiopulmonary bypass. The disadvantage of this surgery is that anticoagulant therapy is required throughout life to prevent the formation of thrombi on the surface of the prosthesis. On the other hand, the advantage is that the heart valve prosthesis can theoretically be used for a lifetime. Therefore, heart valve prostheses are mainly used for young people. Currently, female patients who wish to give birth are almost excluded from this treatment method.
[0004] Biological heart valves are mainly manufactured from the pericardium of cows or pigs, or consist of the entire heart valve of cows or pigs. In addition, the jugular vein valve of cows is used as a heart valve prosthesis. Valves taken from animal tissues are called xenografts. Biological heart valves are transplanted surgically or, since around 2000, as stented heart valves by cardiac catheter intervention.
[0005] Furthermore, biological heart valves can be taken from human valve donors (allografts), or in some cases, from the patient themselves for autotransplantation (e.g., so-called Ross procedure).
Summary of the Invention
Problems to be Solved by the Invention
[0006] Using biomaterials has the advantage of avoiding long-term anticoagulation therapy. However, with the exception of autologous transplants, these heart valves are derived from foreign materials and therefore have the disadvantage of being ultimately rejected by the immune system. This rejection often occurs despite numerous pretreatment steps taken to reduce the risk of immune reactions. As a result of such immune reactions, the transplanted heart valve deteriorates. Therefore, the durability of living heart valves, especially xenografts, is considered to be limited to approximately 5 to 15 years. After that, the heart valve will need to be replaced again.
[0007] Human-derived valves have the advantage of being more durable due to their lower immune response. However, a major drawback is that obtaining these valves is becoming increasingly difficult because they require donations, which are not readily available. Therefore, as a special case, there is the option of self-donation. In a procedure called the Ross procedure, a patient's own pulmonary valve is transplanted in place of a diseased aortic valve, and the missing pulmonary valve is replaced with the aforementioned xenograft or allograft.
[0008] As already mentioned, heart valve prostheses are implanted by surgical, interventional, or hybrid surgery (a combination of surgical and interventional procedures). Percutaneous interventional replacement is based on the use of catheters and the improved Seldinger technique. Interventions are subdivided into transvenous, transarterial, and transcatheter interventions. The transapical approach is performed via a route through the chest wall and apex, passing through the left or right ventricle. In the case of the transvenous approach, the right side of the heart containing the valve is reached from the anterior inferior (i.e., with blood flow). By puncturing the atrial septum, the left side of the heart can also be reached. The transarterial approach allows access to the left ventricle and valve in a retrograde manner.
[0009] The object of the present invention is to provide a method and apparatus for easily manufacturing a heart valve prosthesis that combines long durability and resistance to thrombus formation on its surface. [Means for solving the problem]
[0010] This objective is achieved by the method for manufacturing a heart valve prosthesis mold described in claim 1. This method comprises the steps described below.
[0011] First, three-dimensional image data of a disabled heart valve of an individual is provided. Herein, this image data is obtained by a suitable imaging method prior to carrying out the method described in the claim. Suitable methods include, for example, magnetic resonance imaging (MRI), computed tomography (CT), (three-dimensional) ultrasound (e.g., echocardiography), or three-dimensional rotational angiography.
[0012] Subsequently, the 3D image data is reconstructed in 3D. This at least partially corrects the defect in the faulty heart valve (so-called virtual valve surgery). As a result, reconstructed 3D image data representing a virtual heart valve is obtained. This virtual heart valve has performance that corresponds to that of a healthy heart valve rather than that of a faulty heart valve. The term "performance" should be understood in particular as the ability to open and close in the cardiovascular system or ventricles of the heart. Therefore, a heart valve with good performance has good opening and closing ability in the cardiovascular system or ventricles.
[0013] Subsequently, a virtual 3D model of the heart valve prosthesis is created using the reconstructed 3D image data. Because the reconstructed 3D image data is based on the image data of a specific individual, the virtual 3D model becomes an individually optimized (tailored to each individual) heart valve prosthesis model.
[0014] Then, this virtual 3D model is used to create the actual or real mold of the heart valve prosthesis. More precisely, the virtual 3D model is used to create individually optimized molds for heart valve prostheses.
[0015] Next, using this individually optimized heart valve prosthesis mold, individually optimized heart valve prostheses can be manufactured. This can be done, for example, by using the desired material in the actual mold and applying, for example, positive or negative pressure, suction or vacuum, temperature changes and / or biochemically active substances such as crosslinking agents to shape the filled material into the actual mold. For example, body tissue from a person or animal that needs to obtain an individually optimized heart valve prosthesis can be used to reshape it in the actual mold to obtain an individually optimized heart valve prosthesis.
[0016] In one embodiment, the present invention also relates to a method that includes the step of obtaining three-dimensional image data of a disabled heart valve of an individual by an appropriate imaging method.
[0017] In one embodiment, after the step of reconstructing the three-dimensional image data into three dimensions, the performance of the virtual heart valve represented by the reconstructed three-dimensional image data is tested by simulation. This simulation is performed with respect to the systolic and diastolic blood flow and / or vortices and / or streamlines and / or pressure fields and / or pressure gradients passing through the virtual heart valve. Such simulations allow for a more detailed evaluation of the performance of the virtual heart valve and can confirm that the virtual heart valve actually performs better than the faulty heart valve that is to be replaced. The simulation of the performance of the virtual heart valve is best performed using specialized software.
[0018] In one embodiment, the three-dimensional image data is three-dimensional image data of a heart valve of a person with a disability.
[0019] In one embodiment, the three-dimensional image data is three-dimensional image data of a damaged animal valve. In one embodiment, the animal is a rodent or a non-human mammal.
[0020] In one embodiment, the step of reconstructing the three-dimensional image data in three dimensions includes a step of virtually excising at least one impaired or diseased region of the impaired heart valve (so-called virtual valve surgery). Furthermore, the excised region is then replaced by a reconstructed region having the appearance of healthy tissue, particularly healthy heart tissue. The reconstructed three-dimensional image data then resembles or corresponds to a heart valve without impairment.
[0021] In general, the actual molds for individually optimized heart valve prostheses can be manufactured by any suitable manufacturing method, which in one embodiment is carried out by injection molding or 3D printing. 3D printing is a particularly suitable method because it can manufacture individually optimized molds at low cost and high speed.
[0022] The actual molds of individually optimized heart valve prostheses can be used to manufacture all kinds of heart valve prostheses. Thus, in one embodiment, the mold is for an aortic valve prosthesis. In another embodiment, the mold is for a pulmonary valve prosthesis. In yet another embodiment, the mold is for a mitral valve prosthesis. In yet another embodiment, the mold is for a tricuspid valve prosthesis.
[0023] In one embodiment, the present invention also relates to a (non-transient) computer program product that includes software having executable code that, when executed on a computer, causes the computer to perform the steps described below. First, provided three-dimensional image data of a faulty heart valve of an individual is automatically reconstructed in three dimensions. This at least partially corrects the fault of the faulty heart valve. As a result, reconstructed three-dimensional image data is obtained that represents a virtual heart valve having performance that corresponds to the performance of a non-faulty heart valve rather than the performance of the faulty heart valve.
[0024] Furthermore, this computer program allows the computer to automatically generate a virtual 3D model of the heart valve prosthesis using the reconstructed 3D image data.
[0025] In one embodiment, the software additionally automatically controls the computer to manufacture the actual type for the individually optimized heart prosthesis based on the virtual three-dimensional type. Thus, the computer program can, for example, control a 3D printer to manufacture the actual type (hereinafter also referred to as the physical model) for the individually optimized heart valve prosthesis.
[0026] In one embodiment, before the software automatically generates the virtual three-dimensional type of the heart valve prosthesis, the software causes the computer to perform an additional step, namely, simulating the performance of the virtual heart valve with respect to the systolic and diastolic blood flow and / or vortices and / or streamlines and / or pressure fields and / or pressure gradients passing through the virtual heart valve.
[0027] In one aspect, the present invention also relates to a type for an individually optimized heart valve prosthesis obtained, or obtainable, by the method according to the previous description.
Advantages of the Invention
[0028] All embodiments of the described method can be combined in any way and transplanted into the described computer program product and the type for the individually optimized heart valve prosthesis alone or in any combination. The reverse is also true.
Brief Description of the Drawings
[0029] Further details of aspects of the present invention are described below with respect to exemplary embodiments and the accompanying figures. [Figure 1] It is a flowchart showing a method for manufacturing a type for a heart valve prosthesis. [Figure 2] It is a diagram showing an exemplary embodiment of a type for a heart valve prosthesis. [Figure 3] It is a diagram showing an addition of further components to the type of FIG. 2. [Figure 4]This figure shows the first step in the method of using the mold shown in Figure 2. [Figure 5] This figure shows the second step in the method of using the mold shown in Figure 2. [Figure 6] This figure shows the third step in the method of using the mold shown in Figure 2. [Figure 7] This figure shows the fourth step in the method of using the mold shown in Figure 2. [Figure 8] This figure shows the fifth step in the method of using the mold shown in Figure 2. [Modes for carrying out the invention]
[0030] Figure 1 shows a flowchart of an exemplary embodiment of a method for manufacturing a mold for a heart valve prosthesis. In the first step 100, three-dimensional image data of the heart valve of a person with a disability is provided.
[0031] In the second step 110, the 3D image data is reconstructed. This second step 110 can also be described as virtual heart valve surgery. This step virtually corrects the defects detected in the heart valve of the person from whom the 3D image data was obtained. These defects typically result in more or less significant dysfunction of the person's heart valve. When virtual heart valve surgery 110 is performed, the defects are virtually corrected. Therefore, the reconstructed 3D image data will represent a person's heart valve with superior functional characteristics compared to the person's heart valve from whom the 3D image data was obtained. In other words, the heart valve in the reconstructed 3D image data has superior functionality compared to the original heart valve from which the 3D image data was obtained.
[0032] In the third step 120, the reconstructed 3D image data is used to generate a virtual 3D model for an optimized (personally tailored) heart valve prosthesis.
[0033] Subsequently, in the fourth step 130, a physical mold for the heart valve prosthesis is manufactured using a virtual 3D mold. This physical mold is intended to produce a heart valve prosthesis with superior properties to that of the heart valve from which the 3D image data was obtained.
[0034] Figure 2 shows an exemplary embodiment of a mold for manufacturing a heart valve prosthesis. This mold consists of a first part 1 and a second part 2 that are interlocking with each other. The first part 1 and the second part 2 together function as the negative and positive molds of the heart valve prosthesis to be manufactured.
[0035] Figure 3 shows the first part 1 and second part 2 of the mold shown in Figure 2, with additional parts, namely plate 3, ring 4, gasket 5, and reaction vessel 6. These parts are usually supplied as a set. After placing the cardiac tissue between the first part 1 and second part 2 included in the above mold, it is possible to assemble the first part 1 and second part 2. This cardiac tissue is then secured by ring 4. The assembled first part 1, second part 2, cardiac tissue, and gasket 5 can then be placed in reaction vessel 6. Plate 3 assists in the process of properly positioning the cardiac tissue between the first part 1 and second part 2.
[0036] The individual steps for manufacturing the artificial heart valve using the first component 1 and the second component 2 described above will be described in more detail below with reference to Figures 4 to 8. In all figures, the same reference numerals are used to describe identical or similar elements.
[0037] As shown in Figure 4, the pericardium 7 or other cardiac tissue is placed under tension on the first component 1. This is done using a pair of forceps 8. However, other instruments may also be used.
[0038] As shown in the plan view of Figure 5, the pericardium 7 then completely covers the first component 1. In contrast, the second component 2 is not yet covered by the pericardium. However, the gasket 5 is already positioned around the first component 1.
[0039] As shown in Figure 6, the second component 2 is placed on top of the first component 1, and the pericardium 7 is pressed between the first component 1 and the second component 2. Furthermore, the ring 4 serves to secure the pericardium 7. The pericardium 7 protruding from the second component 2 and the ring 4 is excised with a scalpel 9. This is done on a plate 3 that provides a clean and flat cut surface.
[0040] Figure 7 shows the fully assembled mold with the first component 1 placed over the second component 2, and the ring 4 securing the pericardium 7 to the mold. This fully assembled mold can then be placed in the reaction vessel 6, as shown in Figure 8. A lid (for example, plate 3 shown in Figure 3) can be placed on the top of the reaction vessel 6. The gasket 5 and the reaction vessel gasket 10 provide a tight seal between the inside and outside of the reaction vessel 6.
[0041] The reaction vessel 6 has an inlet 11 and an outlet 12. The reaction liquid can be supplied into the reaction vessel 6 from the inlet 11 and discharged from inside the reaction vessel 6 through the outlet 12.
[0042] In the embodiment shown in Figure 8, a reaction solution containing a crosslinking agent is supplied to the reaction vessel 6. This crosslinking agent crosslinks the pericardium 7, maintaining the shape given to the pericardium 7 by the mold. Therefore, when the first component 1 is removed from the second component 2, the pericardium 7 retains the shape given by the first component 1 and the second component 2, i.e., the shape of the heart valve. After the leaflet is separated, the molded pericardium 7 can then be used as a fully functional heart valve prosthesis.
Claims
1. 1. A method of manufacturing a mold for a heart valve prosthesis, comprising: a) providing 100 three-dimensional image data of a diseased heart valve of an individual, previously acquired by a suitable imaging method; b) at least partially correcting the defects of the failed heart valve by three-dimensionally reconstructing (110) the three-dimensional image data to obtain reconstructed three-dimensional image data representing a virtual heart valve having performance that corresponds more to the performance of a non-faulty heart valve than to the performance of the failed heart valve; c) using the reconstructed three-dimensional image data to generate (120) a virtual three-dimensional mold for an individually optimized heart valve prosthesis; d) using said virtual three-dimensional mold to produce (130) a real mold (1, 2) for a heart valve prosthesis; A method comprising:
2. 10. The method of claim 1, further comprising, after step b), performing a step of simulating the performance of the virtual heart valve with respect to at least one of systolic and diastolic blood flow, vortices, streamlines, pressure fields, and pressure gradients through the virtual heart valve.
3. 3. The method of claim 1, wherein the three-dimensional image data is three-dimensional image data of a failing human heart valve.
4. 3. The method according to claim 1 or 2, characterized in that the three-dimensional image data is three-dimensional image data of a failed heart valve of an animal, in particular a rodent or a non-human mammal.
5. 5. The method of claim 1, wherein the three-dimensional reconstruction (110) of the three-dimensional image data comprises virtually ablating at least one defective or diseased area of the defective heart valve and reshaping the ablated area to have the appearance of healthy tissue.
6. 6. The method according to any one of claims 1 to 5, characterized in that the individually optimized molds (1, 2) for the heart valve prosthesis are manufactured by injection molding or three-dimensional printing.
7. 7. The method according to claim 1, wherein the individually optimized cardiac valve prosthesis mold (1, 2) is a mold for an aortic valve prosthesis, a pulmonary valve prosthesis, a mitral valve prosthesis or a tricuspid valve prosthesis.
8. 1. A computer program product comprising: When run on a computer, a) automatically reconstructing (110) the provided three-dimensional image data of a failed heart valve of an individual into three dimensions, thereby at least partially correcting the defects of the failed heart valve to obtain reconstructed three-dimensional image data representing a virtual heart valve having performance that corresponds more to the performance of a non-faulty heart valve than to the performance of the failed heart valve; b) automatically using the reconstructed three-dimensional image data to generate (120) a virtual three-dimensional mold for a heart valve prosthesis; A computer program product including software having executable code that causes a computer to execute the program.
9. 9. The computer program product of claim 8, wherein the software causes the computer to: c) A computer program product for automatically controlling (130) the production of a real mold (1, 2) for a heart valve prosthesis based on said virtual three-dimensional mold.
10. 10. The computer program product of claim 8 or 9, wherein, prior to performing step b) of claim 8, the software causes the computer to perform the additional step of simulating performance of the virtual heart valve with respect to at least one of systolic and diastolic blood flow, vortices, streamlines, pressure fields and pressure gradients through the virtual heart valve.
11. A mold for an individually optimized heart valve prosthesis obtainable by a method according to any one of claims 1 to 7.
